Lipidomic profiling unveils sex differences in diabetes risk: Implications for precision medicine
European Journal of Clinical Investigation · 2026
DOI: 10.1111/eci.70137 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2026. Verfasst von Ana F Pina und 8 weiteren Autor:innen. Beteiligte Einrichtung: iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisbon, Portugal. Hauptthemen laut MEDLINE: Lipidomics, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission Marie Skłodowska-Curie Action H2020, Sociedade Portuguesa De Diabetologia, European Commission Horizon Europe.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims/Hypothesis Type 2 diabetes is a multifactorial condition whose greatest impact comes from its complications. We hypothesized that distinct insulin‐derived mechanisms and lipid profiles discriminate sex differences and can be used to identify subjects at higher risk to develop diabetes‐related complications.
Methods
The PREVADIAB2 study evaluated metabolic alterations after 5 years in individuals initially free of Type 2 Diabetes (PREVADIAB1). In this analysis, 953 participants were stratified into clusters using hierarchical clustering based on insulinogenic index (IGI), fasting insulin secretion rate, HOMA‐IR, and fasting insulin clearance. A subset of participants ( n = 488) had their lipidome assessed using LC/MS‐QTOF.
Results
Four clusters were identified: Liver Sensitive (LS), Pancreas Glucose Sensitive (PGS), Insulin Deficient (ID), and Insulin Resistant (IR), each with distinct dysglycemia risk. While metabolic features were similar across sexes, the parameter thresholds differed, resulting in sex‐specific lipidomic profiles. Women exhibited higher levels of circulating dihydroceramides (5.3 ± 1.9 vs. 4.7 ± 1.8, p < .001), associated with de novo ceramide synthesis, and elevated sphingomyelins (SM), suggesting altered lipid metabolism. Conversely, the ceramide‐to‐SM ratio was higher in men (1.04 ± .21 vs. .90 ± .18, p < .001). Except for the LS cluster, all other clusters exhibit distinct lipid signatures associated with metabolic dysfunction, further accentuated by specific lipid profile sex differences.
Conclusions
Distinct insulin‐related metabolic features and sex identify different phenotypes with distinct lipidome profiles, highlighting the need to place prediabetes in a broader context of metabolism beyond glucose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisbon, Portugal.
- ProRegeM PhD Program, NOVA Medical School, NMS, Universidade Nova de Lisboa, Lisbon, Portugal.
- APDP - Diabetes Portugal, Education and Research Center, Lisbon, Portugal.
- National Research Council (CNR), Institute of Clinical Physiology (IFC), Pisa, Italy.
- Portuguese Society of Diabetology, Lisbon, Portugal.
- Scuola Superiore Sant'Anna, Pisa, Italy.
ORCID-Profile: Maria João Meneses
Förderung
- European Commission Marie Skłodowska-Curie Action H2020
- Sociedade Portuguesa De Diabetologia
- European Commission Horizon Europe
- COMPETE 2020
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Pina, A. F., Meneses, M. J., Carli, F., Ribeiro, R. T., Gardete-Correia, L., Boavida, J. M., Raposo, J. F., Gastaldelli, A., & Macedo, M. P. (2026). Lipidomic profiling unveils sex differences in diabetes risk: Implications for precision medicine. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70137
Vancouver
Pina AF, Meneses MJ, Carli F, Ribeiro RT, Gardete-Correia L, Boavida JM, et al. Lipidomic profiling unveils sex differences in diabetes risk: Implications for precision medicine. European Journal of Clinical Investigation. 2026. doi:10.1111/eci.70137
BibTeX
@article{Pina2026,
author = {Pina, Ana F and Meneses, Maria João and Carli, Fabrizia and Ribeiro, Rogério T and Gardete-Correia, Luís and Boavida, José M and Raposo, João F and Gastaldelli, Amalia and Macedo, M Paula},
title = {Lipidomic profiling unveils sex differences in diabetes risk: Implications for precision medicine},
journal = {European Journal of Clinical Investigation},
year = {2026},
doi = {10.1111/eci.70137}
}
EUVIMED